Pharmaceutical Contract Manufacturing Market 2023 – 2030 By Biologic (API, FDF), Drug Development), End User (Big Pharma, Small & Medium-sized Pharma, Generic Pharma), Service (Pharmaceutical (API, FDF - Tablet, Capsule, Injectable)) - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 180 Pages | Published On : Dec 2023

         
     

The Pharmaceutical Contract Manufacturing Market size is estimated to grow from USD 188.16 Billion in 2022 to reach USD 318.96 Billion by 2030, growing at a CAGR of 6.82% during the forecast period from 2023 to 2030.

Pharmaceutical Contract Manufacturing Market Size


Graph
             2022                         2023-2030      

ReportDetails
Market Size ValueUSD 188.16 Billion in 2022
Market Size ValueUSD 318.96 Billion by 2030
CAGR6.82%
Forecast Period2023-2030
Historic Data2022
Segments CoveredServices, End-user, and Region
Geographics CoveredNorth America, Latin America, Europe, Asia-Pacific, Middle East & Africa

Major players in Pharmaceutical Contract Manufacturing Market include: Abbvie, Inc., Thermo Fisher Scientific, Inc., Lonza Group, Catalent, Inc., Evonik Industries Ag, Samsung Biologics, Fujifilm Holdings Corporation, Siegfried Holding Ag, Eurofins Scientific, Wuxi Apptec, Boehringer Ingelheim International Gmbh, Recipharm AB, Vetter Pharma, Piramal Pharma Solutions, and Almac Group

Increase in Demand for Generic Drugs

Generic pharmaceuticals are identical or bioequivalent versions of brand-name prescriptions, but they are marketed at a reduced cost since they do not require the same amount of research and development effort. This affordability has made generic pharmaceuticals more accessible to individuals, healthcare providers, and healthcare systems.

Globally rising healthcare expenses are one of the key reasons for rising demand for generic pharmaceuticals. Many countries' healthcare systems are under pressure to keep costs under control while providing high-quality medical treatment to an aging population. Generic medications provide a cost-effective answer because they are often 30% to 80% less expensive than brand-name equivalents. Patients and healthcare providers are increasingly turning to generic alternatives to cut healthcare costs while maintaining therapeutic efficacy.

Additionally, government initiatives and regulations supporting the use of generic pharmaceuticals have played an important role in increasing demand. Many governments have developed generic substitution policies, which encourage or require the use of generic medications when they are available. Such initiatives are frequently motivated by the desire to reduce healthcare costs and improve patient access to important pharmaceuticals. In some circumstances, healthcare providers may be compensated for recommending generic pharmaceuticals, further encouraging their use.

In addition, the rising prevalence of chronic diseases and age-related ailments has increased the demand for long-term pharmaceuticals. Chronic illnesses frequently necessitate ongoing pharmacological therapy, resulting in substantial prescription expenses for patients. Because generic medications are more affordable, patients are more likely to stick to their prescribed prescriptions, resulting in improved illness control. However, despite the rising demand for generic medications, specific challenges persist. Some patients and healthcare providers may hesitate to convert from brand-name to generic pharmaceuticals due to worries about efficacy or potential formulation variations. Pharmaceutical companies must address these concerns by undertaking rigorous bioequivalence studies that establish the similarity of generic medications to brand-name equivalents.

Moreover, as the generic pharmaceutical industry evolves, pharmaceutical companies and healthcare stakeholders will need to work together to assure the availability and quality of generic drugs to satisfy the demands of patients and healthcare systems.

Growing prevalence of complex diseases and the emergence of biologics and advanced therapies

The emergence of biologics and cutting-edge medicines as well as the rising prevalence of complex disorders are two interrelated variables that have had a major impact on the healthcare environment. Traditional therapy modalities frequently fall short in offering efficient remedies as the burden of complicated diseases, such as cancer, autoimmune disorders, and chronic problems, continues to climb internationally. A new age in medical science has begun as a result of the investigation and creation of novel biologics and cutting-edge treatments.

The recent development of biologics has completely changed the pharmaceutical sector and led to substantial investments in R&D. Biologics are complex, requiring state-of-the-art manufacturing techniques and specialized equipment. As a result, the market for pharmaceutical contract manufacturing has experienced rapid expansion as pharmaceutical companies look for knowledge in large-scale biologic production. A major part of ensuring the effective and economical production of biologics is played by contract manufacturers with advanced bioprocessing capabilities, enabling more patient access to these potentially life-saving treatments.

Furthermore, the growing prevalence of complicated diseases has prompted collaborations among pharmaceutical companies, research institutes, and contract manufacturers to hasten the discovery and marketing of novel therapeutics. These agreements promote knowledge sharing, expertise exchange, and resource pooling, all of which contribute to breakthroughs in biological and advanced therapeutic manufacturing processes.

Regional Insight

North America, which comprises the United States and Canada, is a major center for pharmaceutical production and research, making it a popular location for contract manufacturing services. North American pharmaceutical corporations are progressively outsourcing their manufacturing operations to contract manufacturers. Outsourcing allows pharmaceutical businesses to concentrate on their core competencies, such as research and development, while contract manufacturers manage the production and supply chain components of medication manufacturing. In addition, the increased emphasis on specialist therapeutics such as biologics, personalized medications, and gene therapies necessitates the development of specialized manufacturing capabilities. Contract manufacturers frequently have the skills and infrastructure to handle the complicated production procedures associated with these sophisticated treatments, making them an appealing alternative for pharmaceutical companies.

Moreover, the biopharmaceutical market in North America is expanding fast, mainly to advances in biotechnology and the rising frequency of chronic diseases. Contract manufacturers play an important role in assisting biopharmaceutical businesses in efficiently bringing their novel drugs to market.

The Pharmaceutical Contract Manufacturing Market research report provides an in-depth overview of the industry including market segmentation by Services, End-user, and Region. Analysis of the global market with a special focus on high-growth applications in each vertical and fast-growing market segment. It includes a detailed competitive landscape with identification of the key players concerning each type of market, in-depth market share analysis with individual revenue, market shares, and top players’ rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, and game-changing developments such as new product launches, collaborations, expansions, investment analysis, mergers, and acquisitions. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.

The report further studies the market strategies of key players, recent development status, plans, and Pharmaceutical Contract Manufacturing Market trends across the world. Also, it splits the market segmentation further to deep dive into research and reveals company profile and prospects.

Major Classifications are as follows:

  • By Services
    • Active Pharmaceutical Ingredient (API) Manufacturing Services
    • Biopharmaceutical Contract Manufacturing / Biomanufacturing Services
    • Bioprocess and Biologics Development Services
    • Bioprocess Engineering Services
    • Custom Peptide Synthesis Services
    • Large-Scale Protein Production Services
    • Contract Clinical Trial Materials (CTM) Manufacturing Services
    • Liquid and Semi-Solid Dosage Form Contract Manufacturing Services
    • Potent Compound and Cytotoxic Therapy Manufacturing Services
    • Solid Dosage Forms Contract Manufacturing Services
  • By End-user
    • Big Pharmaceutical Companies
    • Biotechnology Companies
    • Biopharma Companies
    • Generic Pharmaceutical Companies
    • Academic Institutes,
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia Pacific
    • Rest of the World
      • Middle East
        • UAE
        • Saudi Arabia
        • Israel
        • Rest of the Middle East
      • Africa
        • South Africa
        • Rest of the Middle East & Africa

Reason to Purchase this Pharmaceutical Contract Manufacturing Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Pharmaceutical Contract Manufacturing Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Pharmaceutical Contract Manufacturing Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Pharmaceutical Contract Manufacturing Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Pharmaceutical Contract Manufacturing Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Pharmaceutical Contract Manufacturing Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
    5. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  3. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
    7. Pricing Analysis
      1. Pricing Analysis, By Products
      2. Average Pricing Benchmark Analysis
  4. Pharmaceutical Contract Manufacturing Market, By Services
    1. Active Pharmaceutical Ingredient (API) Manufacturing Services
    2. Biopharmaceutical Contract Manufacturing / Biomanufacturing Services
    3. Bioprocess and Biologics Development Services
    4. Bioprocess Engineering Services
    5. Custom Peptide Synthesis Services
    6. Large-Scale Protein Production Services
    7. Contract Clinical Trial Materials (CTM) Manufacturing Services
    8. Liquid and Semi-Solid Dosage Form Contract Manufacturing Services
    9. Potent Compound and Cytotoxic Therapy Manufacturing Services
    10. Solid Dosage Forms Contract Manufacturing Services
  5. Pharmaceutical Contract Manufacturing Market, By End-User
    1. Big Pharmaceutical Companies
    2. Biotechnology Companies
    3. Biopharma Companies
    4. Generic Pharmaceutical Companies
    5. Academic Institutes,
    6. Others
  6. Pharmaceutical Contract Manufacturing Market, By Geography
    1. Pharmaceutical Contract Manufacturing Market, North America
      1. U.S.
      2. Canada
    2. Pharmaceutical Contract Manufacturing Market, Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Pharmaceutical Contract Manufacturing Market, Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Pharmaceutical Contract Manufacturing Market, Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Pharmaceutical Contract Manufacturing Market, Rest of the world
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  7. Competitive Analysis
    1. Introduction
    2. Top Companies Ranking
    3. Competitive Landscape
      1. Competition Dashboard
      2. Market Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. Abbvie, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Thermo Fisher Scientific, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Lonza Group
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      4. Catalent, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. Evonik Industries Ag
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. Samsung Biologics
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. Fujifilm Holdings Corporation
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. Siegfried Holding Ag
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. Eurofins Scientific
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. Wuxi Apptec
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. Boehringer Ingelheim International Gmbh
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. Recipharm AB
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. Vetter Pharma
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. Piramal Pharma Solutions
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. Almac Group
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com